These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3698686)

  • 1. Role of lymphocytotoxicity and staph-protein A assays in platelet donor selection.
    Bonacossa IA; Perchotte MR; Olchowecki JK; Schroeder ML
    Curr Stud Hematol Blood Transfus; 1986; (52):58-64. PubMed ID: 3698686
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of three cross-match techniques to select platelet donors. Lymphocytotoxicity, platelet suspension immunofluorescence test, and enzyme-linked immunosorbent assay.
    Bowen TJ; Berman-Wong E; Dawson D; Herbut B; Smith L; Snider C; Hill L
    Curr Stud Hematol Blood Transfus; 1986; (52):47-57. PubMed ID: 3516584
    [No Abstract]   [Full Text] [Related]  

  • 3. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
    Wu KK; Hoak JC; Koepke JA; Thompson JS
    Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four crossmatch methods to select platelet donors.
    Kakaiya RM; Gudino MD; Miller WV; Sherman LA; Katz AJ; Wakem CJ; Krugman DJ; Klatsky AU; Kiraly TR
    Transfusion; 1984; 24(1):35-41. PubMed ID: 6364475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of platelet alloimmunity with a platelet-associated IgG assay.
    Myers TJ; Kim BK; Steiner M; Bishop J; Baldini MG
    J Lab Clin Med; 1981 Jun; 97(6):854-63. PubMed ID: 7014743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet crossmatching with Capture P: clinical relevance.
    Böck M; Heim MU; Schleich I; Weindler R; Wagner M; Mempel W
    Infusionstherapie; 1989 Aug; 16(4):183-5. PubMed ID: 2807565
    [No Abstract]   [Full Text] [Related]  

  • 11. Random donor platelet cross-matching.
    Freedman J
    Curr Stud Hematol Blood Transfus; 1986; (52):65-70. PubMed ID: 3698687
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.
    Daly PA; Schiffer CA; Aisner J; Wiernik PH
    JAMA; 1980 Feb; 243(5):435-8. PubMed ID: 7351763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
    Brand A; van Leeuwen A; Eernisse JG; van Rood JJ
    Blood; 1978 May; 51(5):781-8. PubMed ID: 346088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
    Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
    Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selection of compatible thrombocyte donors using a solid-phase immunoassay in polytransfused patients].
    Bade L; Gerdes R; Keller E; Rogge T
    Beitr Infusionsther; 1988; 21():299-303. PubMed ID: 2462997
    [No Abstract]   [Full Text] [Related]  

  • 16. Matching of histocompatibility (HL-A) antigens for platelet transfusion.
    Mittal KK; Ruder EA; Green D
    Blood; 1976 Jan; 47(1):31-41. PubMed ID: 1244913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of platelet antibodies using the platelet migration inhibition assay.
    Levine SJ; Brubaker DB
    Am J Clin Pathol; 1983 Jul; 80(1):43-8. PubMed ID: 6858964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion: automated selection of donors.
    Muller JY; Cartron JP; Trillot P; Halle L; Roquin H
    Transfusion; 1981; 21(3):261-7. PubMed ID: 7233510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The hematological and immunological effects of platelet concentrate transfusions on surgical patients in platelet depleted states].
    Umeki Y
    Masui; 1985 Jun; 34(6):846-60. PubMed ID: 4032712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.